Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -46,378 | N/A | N/A |
| Depreciation Amortization | 111 | N/A | N/A |
| Accounts receivable | 777 | N/A | N/A |
| Other Working Capital | 6,507 | N/A | N/A |
| Other Operating Activity | -160 | 0 | 0 |
| Operating Cash Flow | $-39,143 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -352 | N/A | N/A |
| Investing Cash Flow | $-352 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 81,830 | 0 | 0 |
| Financing Cash Flow | $81,830 | $N/A | $N/A |
| Beginning Cash Position | 25,154 | N/A | N/A |
| End Cash Position | 67,489 | N/A | N/A |
| Net Cash Flow | $42,335 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -39,143 | N/A | N/A |
| Capital Expenditure | -352 | N/A | N/A |
| Free Cash Flow | -39,495 | 0 | 0 |